Potential of particulate carriers for the mucosal delivery of DNA vaccines.
Alpar
H O
HO
Pharmaceutical Sciences Institute, Aston University, Birmingham, U.K.
Ozsoy
Y
Y
Bowen
J
J
Eyles
J E
JE
Conway
B R
BR
Williamson
E D
ED
D000281:Administration, Intranasal; D000818:Animals; D000917:Antibody Formation; D001672:Biocompatible Materials; D003001:Cloning, Molecular; D004337:Drug Carriers; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007273:Injections, Intramuscular; D007840:Latex; D051379:Mice; D008807:Mice, Inbred BALB C; D008863:Microspheres; D009297:Nasal Mucosa; D010047:Ovalbumin / Q000096:biosynthesis; D010714:Phosphatidylethanolamines; D010957:Plasmids; D011091:Polyesters; D011994:Recombinant Proteins / Q000096:biosynthesis; D019444:Vaccines, DNA / Q000008:administration & dosage*
D001672:Biocompatible Materials; D004337:Drug Carriers; D007074:Immunoglobulin G; D007840:Latex; D010714:Phosphatidylethanolamines; D011091:Polyesters; D011994:Recombinant Proteins; D019444:Vaccines, DNA; C033616:poly(lactide); C020888:1,2-dielaidoylphosphatidylethanolamine; D010047:Ovalbumin